Chad E. Schroeder
7Patents
2h-index
21Co-inventors
43Inventor score
Filing activity: Feb 24, 2012 → Oct 1, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9642835B2 | Modulators of GTPase and use in relevant treatment | Emerging Cross-Sectional Technologies | 4 | Active |
| US8765803B1 | Rab7 GTPase inhibitors and related methods of treatment | Human Necessities | 2 | Active |
| US9056111B1 | Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment | Human Necessities | 1 | Active |
| US9580393B2 | 6-substituted quinazolinone inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10532999B2 | 6-substituted quinazolinone inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9376452B2 | Rab7 GTPase inhibitors and related methods of treatment | Human Necessities | 0 | Active |
| US10087168B2 | 6-substituted quinazolinone inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.